García-Carmona JA - Search Results

1

Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study.

García-Carmona JA, García-Pérez A, Isidro García G, Forcen-Muñoz LA, Ovejero García S, Sáez Povedano R, González-Galdámez AL, Mata Iturralde L, Hernández-Sánchez F, Ramirez Bonilla M, Fuentes-Pérez P, Ovejas-Catalán C, Suárez-Pinilla P, Valdivia-Muñoz F, Fernández Abascal B, Omaña Colmenares M, de Lourdes Martín-Pérez Á, Campos-Navarro MP, Baca-García E, Benavente-López S, Raya Platero A, Barberán Navalón M, Sánchez-Alonso S, Vázquez-Bourgon J, Pappa S. García-Carmona JA, et al. Ther Adv Psychopharmacol. 2023 Dec 26;13:20451253231220907. doi: 10.1177/20451253231220907. eCollection 2023. Ther Adv Psychopharmacol. 2023. PMID: 38152569 Free PMC article.

2

Evaluation of long-acting injectable antipsychotics with the corresponding oral formulation in a cohort of patients with schizophrenia: a real-world study in Spain.

García-Carmona JA, Simal-Aguado J, Campos-Navarro MP, Valdivia-Muñoz F, Galindo-Tovar A. García-Carmona JA, et al. Int Clin Psychopharmacol. 2021 Jan;36(1):18-24. doi: 10.1097/YIC.0000000000000339. Int Clin Psychopharmacol. 2021. PMID: 33086252

3

Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal.

García-Carmona JA, Pappa S. García-Carmona JA, et al. Drug Healthc Patient Saf. 2023 Sep 12;15:113-123. doi: 10.2147/DHPS.S339170. eCollection 2023. Drug Healthc Patient Saf. 2023. PMID: 37720806 Free PMC article. Review.

4

Long-Acting Injectable Antipsychotics: Analysis of Prescription Patterns and Patient Characteristics in Mental Health from a Spanish Real-World Study.

García-Carmona JA, Simal-Aguado J, Campos-Navarro MP, Valdivia-Muñoz F, Galindo-Tovar A. García-Carmona JA, et al. Clin Drug Investig. 2020 May;40(5):459-468. doi: 10.1007/s40261-020-00913-7. Clin Drug Investig. 2020. PMID: 32274654

5

Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain.

García-Carmona JA, Simal-Aguado J, Campos-Navarro MP, Valdivia-Muñoz F, Galindo-Tovar A. García-Carmona JA, et al. Int Clin Psychopharmacol. 2021 Jul 1;36(4):201-207. doi: 10.1097/YIC.0000000000000357. Int Clin Psychopharmacol. 2021. PMID: 33853106

6

Evaluation of Risk Factors Associated to Prescription of Benzodiazepines and its Patterns in a Cohort of Patients from Mental Health: A Real World Study in Spain.

Simal-Aguado J, Campos-Navarro MP, Valdivia-Muñoz F, Galindo-Tovar A, García-Carmona JA. Simal-Aguado J, et al. Among authors: garcia carmona ja. Psychopharmacol Bull. 2021 Jan 12;51(1):81-93. Psychopharmacol Bull. 2021. PMID: 33897065 Free PMC article.

7

Switching from clozapine to paliperidone palmitate-3-monthly improved obesity, hyperglycemia and dyslipidemia lowering antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort.

Martínez-Andrés JA, García-Carmona JA. Martínez-Andrés JA, et al. Int Clin Psychopharmacol. 2020 May;35(3):163-169. doi: 10.1097/YIC.0000000000000300. Int Clin Psychopharmacol. 2020. PMID: 31851035

8

Restricted role of CRF1 receptor for the activity of brainstem catecholaminergic neurons in the negative state of morphine withdrawal.

Garcia-Carmona JA, Almela P, Baroja-Mazo A, Milanes MV, Laorden ML. Garcia-Carmona JA, et al. Psychopharmacology (Berl). 2012 Mar;220(2):379-93. doi: 10.1007/s00213-011-2478-y. Epub 2011 Sep 21. Psychopharmacology (Berl). 2012. PMID: 21947312

9

Clozapine, a controversial gold standard antipsychotic for the 21st century: Switching to paliperidone palmitate 3-monthly improves the metabolic profile and lowers antipsychotic dose equivalents in a treatment-resistant schizophrenia cohort.

Martínez-Andrés JA, García-Carmona JA. Martínez-Andrés JA, et al. Schizophr Res. 2019 Oct;212:234-236. doi: 10.1016/j.schres.2019.08.001. Epub 2019 Aug 15. Schizophr Res. 2019. PMID: 31421972 No abstract available.

10

Brain stress system response after morphine-conditioned place preference.

García-Carmona JA, Milanés MV, Laorden ML. García-Carmona JA, et al. Int J Neuropsychopharmacol. 2013 Oct;16(9):1999-2011. doi: 10.1017/S1461145713000588. Epub 2013 Jun 10. Int J Neuropsychopharmacol. 2013. PMID: 23745716 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

26 results

Search Page